ヒドロキシクロロキン薬の世界市場2021-2026:マラリア、関節リウマチ、新型コロナウイルス感染症、全身性エリテマトーデス、その他

LP Informationが発行した調査報告書(LPI21JL16648)
◆英語タイトル:Global Hydroxychloroquine Drug Market Growth 2021-2026
◆商品コード:LPI21JL16648
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:138
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LP Information社の「ヒドロキシクロロキン薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、マラリア、関節リウマチ、新型コロナウイルス感染症、全身性エリテマトーデス、その他など、用途別には、病院薬局、小売薬局、オンライン薬局などにセグメント区分してまとめました。ヒドロキシクロロキン薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・ヒドロキシクロロキン薬の世界市場概要(サマリー)
・ヒドロキシクロロキン薬の企業別販売量・売上
・ヒドロキシクロロキン薬の企業別市場シェア
・ヒドロキシクロロキン薬の世界市場規模 2016年-2021年:種類別(マラリア、関節リウマチ、新型コロナウイルス感染症、全身性エリテマトーデス、その他)
・ヒドロキシクロロキン薬の世界市場規模 2016年-2021年:用途別(病院薬局、小売薬局、オンライン薬局)
・ヒドロキシクロロキン薬の南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・ヒドロキシクロロキン薬のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・ヒドロキシクロロキン薬のヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ヒドロキシクロロキン薬の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・ヒドロキシクロロキン薬市場の成長要因・課題・動向
・ヒドロキシクロロキン薬の世界市場予測 2021年-2026年
・ヒドロキシクロロキン薬の南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・ヒドロキシクロロキン薬のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・ヒドロキシクロロキン薬のヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ヒドロキシクロロキン薬の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・ヒドロキシクロロキン薬の世界市場予測:種類別(マラリア、関節リウマチ、新型コロナウイルス感染症、全身性エリテマトーデス、その他)
・ヒドロキシクロロキン薬の世界市場予測:用途別(病院薬局、小売薬局、オンライン薬局)
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Hydroxychloroquine Drug will have significant change from previous year. By the most conservative estimates of global Hydroxychloroquine Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Hydroxychloroquine Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Hydroxychloroquine Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Malaria
Rheumatoid Arthritis
COVID-19
Systemic Lupus Erythematosus
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Sanofi
Amneal Pharmaceuticals
Mylan
Teva Pharmaceutical
Novartis
Zydus Cadila
Dr. Reddy’s Laboratories
Sun Pharmaceutical
Lupin Limited
Prasco Laboratories

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hydroxychloroquine Drug Consumption 2016-2026
2.1.2 Hydroxychloroquine Drug Consumption CAGR by Region
2.2 Hydroxychloroquine Drug Segment by Type
2.2.1 Malaria
2.2.2 Rheumatoid Arthritis
2.2.3 COVID-19
2.2.4 Systemic Lupus Erythematosus
2.2.5 Others
2.3 Hydroxychloroquine Drug Sales by Type
2.3.1 Global Hydroxychloroquine Drug Sales Market Share by Type (2016-2021)
2.3.2 Global Hydroxychloroquine Drug Revenue and Market Share by Type (2016-2021)
2.3.3 Global Hydroxychloroquine Drug Sale Price by Type (2016-2021)
2.4 Hydroxychloroquine Drug Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Hydroxychloroquine Drug Sales by Application
2.5.1 Global Hydroxychloroquine Drug Sale Market Share by Application (2016-2021)
2.5.2 Global Hydroxychloroquine Drug Revenue and Market Share by Application (2016-2021)
2.5.3 Global Hydroxychloroquine Drug Sale Price by Application (2016-2021)

3 Global Hydroxychloroquine Drug by Company
3.1 Global Hydroxychloroquine Drug Sales Market Share by Company
3.1.1 Global Hydroxychloroquine Drug Sales by Company (2019-2021)
3.1.2 Global Hydroxychloroquine Drug Sales Market Share by Company (2019-2021)
3.2 Global Hydroxychloroquine Drug Revenue Market Share by Company
3.2.1 Global Hydroxychloroquine Drug Revenue by Company (2019-2021)
3.2.2 Global Hydroxychloroquine Drug Revenue Market Share by Company (2019-2021)
3.3 Global Hydroxychloroquine Drug Sale Price by Company
3.4 Global Manufacturers Hydroxychloroquine Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hydroxychloroquine Drug Product Location Distribution
3.4.2 Players Hydroxychloroquine Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Hydroxychloroquine Drug by Region
4.1 Global Hydroxychloroquine Drug by Region
4.1.1 Global Hydroxychloroquine Drug Sales by Region
4.1.2 Global Hydroxychloroquine Drug Revenue by Region
4.2 Americas Hydroxychloroquine Drug Sales Growth
4.3 APAC Hydroxychloroquine Drug Sales Growth
4.4 Europe Hydroxychloroquine Drug Sales Growth
4.5 Middle East & Africa Hydroxychloroquine Drug Sales Growth

5 Americas
5.1 Americas Hydroxychloroquine Drug Sales by Country
5.1.1 Americas Hydroxychloroquine Drug Sales by Country (2016-2021)
5.1.2 Americas Hydroxychloroquine Drug Revenue by Country (2016-2021)
5.2 Americas Hydroxychloroquine Drug Sales by Type
5.3 Americas Hydroxychloroquine Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Hydroxychloroquine Drug Sales by Region
6.1.1 APAC Hydroxychloroquine Drug Sales by Region (2016-2021)
6.1.2 APAC Hydroxychloroquine Drug Revenue by Region (2016-2021)
6.2 APAC Hydroxychloroquine Drug Sales by Type
6.3 APAC Hydroxychloroquine Drug Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Hydroxychloroquine Drug by Country
7.1.1 Europe Hydroxychloroquine Drug Sales by Country (2016-2021)
7.1.2 Europe Hydroxychloroquine Drug Revenue by Country (2016-2021)
7.2 Europe Hydroxychloroquine Drug Sales by Type
7.3 Europe Hydroxychloroquine Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Hydroxychloroquine Drug by Country
8.1.1 Middle East & Africa Hydroxychloroquine Drug Sales by Country (2016-2021)
8.1.2 Middle East & Africa Hydroxychloroquine Drug Revenue by Country (2016-2021)
8.2 Middle East & Africa Hydroxychloroquine Drug Sales by Type
8.3 Middle East & Africa Hydroxychloroquine Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Hydroxychloroquine Drug Distributors
10.3 Hydroxychloroquine Drug Customer

11 Global Hydroxychloroquine Drug Market Forecast
11.1 Global Hydroxychloroquine Drug Forecast by Region
11.1.1 Global Hydroxychloroquine Drug Forecast by Regions (2021-2026)
11.2.2 Global Hydroxychloroquine Drug Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Hydroxychloroquine Drug Forecast by Type
11.7 Global Hydroxychloroquine Drug Forecast by Application

12 Key Players Analysis
12.1 Sanofi
12.1.1 Sanofi Company Information
12.1.2 Sanofi Hydroxychloroquine Drug Product Offered
12.1.3 Sanofi Hydroxychloroquine Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Sanofi Main Business Overview
12.1.5 Sanofi Latest Developments
12.2 Amneal Pharmaceuticals
12.2.1 Amneal Pharmaceuticals Company Information
12.2.2 Amneal Pharmaceuticals Hydroxychloroquine Drug Product Offered
12.2.3 Amneal Pharmaceuticals Hydroxychloroquine Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Amneal Pharmaceuticals Main Business Overview
12.2.5 Amneal Pharmaceuticals Latest Developments
12.3 Mylan
12.3.1 Mylan Company Information
12.3.2 Mylan Hydroxychloroquine Drug Product Offered
12.3.3 Mylan Hydroxychloroquine Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Mylan Main Business Overview
12.3.5 Mylan Latest Developments
12.4 Teva Pharmaceutical
12.4.1 Teva Pharmaceutical Company Information
12.4.2 Teva Pharmaceutical Hydroxychloroquine Drug Product Offered
12.4.3 Teva Pharmaceutical Hydroxychloroquine Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Teva Pharmaceutical Main Business Overview
12.4.5 Teva Pharmaceutical Latest Developments
12.5 Novartis
12.5.1 Novartis Company Information
12.5.2 Novartis Hydroxychloroquine Drug Product Offered
12.5.3 Novartis Hydroxychloroquine Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Novartis Main Business Overview
12.5.5 Novartis Latest Developments
12.6 Zydus Cadila
12.6.1 Zydus Cadila Company Information
12.6.2 Zydus Cadila Hydroxychloroquine Drug Product Offered
12.6.3 Zydus Cadila Hydroxychloroquine Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Zydus Cadila Main Business Overview
12.6.5 Zydus Cadila Latest Developments
12.7 Dr. Reddy’s Laboratories
12.7.1 Dr. Reddy’s Laboratories Company Information
12.7.2 Dr. Reddy’s Laboratories Hydroxychloroquine Drug Product Offered
12.7.3 Dr. Reddy’s Laboratories Hydroxychloroquine Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Dr. Reddy’s Laboratories Main Business Overview
12.7.5 Dr. Reddy’s Laboratories Latest Developments
12.8 Sun Pharmaceutical
12.8.1 Sun Pharmaceutical Company Information
12.8.2 Sun Pharmaceutical Hydroxychloroquine Drug Product Offered
12.8.3 Sun Pharmaceutical Hydroxychloroquine Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Sun Pharmaceutical Main Business Overview
12.8.5 Sun Pharmaceutical Latest Developments
12.9 Lupin Limited
12.9.1 Lupin Limited Company Information
12.9.2 Lupin Limited Hydroxychloroquine Drug Product Offered
12.9.3 Lupin Limited Hydroxychloroquine Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Lupin Limited Main Business Overview
12.9.5 Lupin Limited Latest Developments
12.10 Prasco Laboratories
12.10.1 Prasco Laboratories Company Information
12.10.2 Prasco Laboratories Hydroxychloroquine Drug Product Offered
12.10.3 Prasco Laboratories Hydroxychloroquine Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Prasco Laboratories Main Business Overview
12.10.5 Prasco Laboratories Latest Developments

13 Research Findings and Conclusion

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ヒドロキシクロロキン薬の世界市場2021-2026:マラリア、関節リウマチ、新型コロナウイルス感染症、全身性エリテマトーデス、その他(Global Hydroxychloroquine Drug Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。